ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 747651 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 747651; 2) Community: the network communities that were significantly associated with the response to NSC 747651; 3) Molecule: the relationships between components within communities and NSC 747651; 4) MDR: the compounds that were significantly associated with the NSC 747651.

NSC Compound Enrichment Correlation
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.00166185890990728 0.52826123
NSC 704113 Null 0.00166185890990728 0.45594973
NSC 705871 1H-Indole, 5-bromo-3-[2-(2-pyridinyl)-4-thiazolyl]- 0.00166185890990728 0.26466277
NSC 715664 Phenol, 4-(5,6-dimethyl-1H-benzimidazol-2-yl)- 2,6-bis(1,1-dimethylethyl)- 0.00166185890990728 0.42885782
NSC 169774 Bromocriptine methanesulfonate 0.00166561193816139 0.53447936
NSC 295641 Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester 0.00166561193816139 0.35750602
NSC 644644 Null 0.00166561193816139 -0.2506198
NSC 736164 pyrazoline derivative 0.00166561193816139 0.57329369
NSC 736914 Null 0.00166561193816139 0.73551906
NSC 176328 Ellipticine, 6-(3-aminopropyl)-, dihydrochloride 0.00189155427362373 0.53971851
Total:62  Current:4    [First] [Prev] [Next] [Last]